CTSI
 
Active Research Protocols

Protocols Seeing at Least 1 Patient in Previous 12 Months
(current as of Apr 13, 2007 10:52 AM)

Investigator
Title
Category
 Aberg
 "AACTG A5197: A Phase II Double-Blind, Randomized, Placebo-Controlled Study to
 A
 Aberg
 "AACTG A5216: A Randomized Phase II Study of the Safety, Immunologic and Virologic Effects of Cyclosporine A in Conjunction with Trizivir and Kaletra versus Trizivir and Kaletra Alone during Primary HIV-1 Infection"
 A
 Aberg
 "ACTG A5175: A Phase IV, Prospective, Randomized, Open-Label Evaluation of the Efficacy of Once-Daily Protease Inhibitor and Once-Daily Non-Nucleoside Reverse Transcriptase Inhibitor-Containing Therapy Combinations for Initial Treatment of HIV-1 Infected Individuals from Resource-Limited Settings (PEARLS) Trial"
 A
 Aberg
 "ACTG A5209: A Pilot Study of the Safety, Efficacy, and Tolerability of Ezetimibe (ZETIA) in Combination with Statin Therapy for the Treatment of Elevated LDL Cholesterol in HIV-Infected Subjects"
 A
 Aberg
 "ACTG A5229: A Phase II/III, Randomized, Double-Blind, Placebo-Controlled Trial of Uridine Supplementation in HIV Lipoatrophy"
 A
 Aberg
 ACTG 362: A Randomized, Placebo Controlled, Trial to Determine the Efficacy of Azithromycin Prophylaxis for the Primary Prevention of Mycobacterium Avium Complex (MAC) Disease and other Infections in Subjects who have Achieved an Increase in CD4 cells on Antiretroviral Therapy
 A
 Aberg
 ACTG A5001: ACTG Longitudinal Linked Randomized Trials (ALLRT) Protocol
 A
 Aberg
 ACTG A5068: A Randomized Phase I/II Pilot Study of Intermittent Withdrawal of Antiretroviral Therapy as an Immunization Strategy and Double-Blinded Immunization with ALVAC-HIV vCP1452 in Subjects with Persistent CD4+ Cell Counts Greater than 500 Cells/mm3 and Plasma HIV-1 RNA Levels <50 Copies/ml
 A
 Aberg
 ACTG A5142: A Phase III, Randomized, Open-Label Comparision of Lopinavir/Ritonavir Plus Efavirenz Versus Lopinavir/Ritonavir Plus Stavudine Extended Release (or Zidovudine) Plus Lamivudine Versus Efavirenz Plus Stavudine Extended Release (or Zidovudine) Plus Lamivudine for the Initial Therapy of HIV-1 Infection
 A
 Aberg
 ACTG A5164: A Phase IV Study of Antiretroviral Therapy for HIV-Infected Adults Presenting with Acute Opportunistic Infections: Immediate Versus Delayed Initiation
 A
 Aberg
 ACTG A5178: Suppressive Long-Term Antiviral Management of Hepatitis C Virus (HCV) and HIV-1 Coinfected Subjects (SLAM-C)
 A
 Aberg
 ACTG A5202: A Phase IIIB Randomized Trial of Open-Label Efavirenz or Atazanavir with Ritonavir in Combination with Double-Blind Comparison of Emtricitabine/Tenofovir or Abacavir/Lamivudine in Antiretroviral-Naive Subjects
 A
 Aberg
 ACTG A5206: A Pilot Study to Determine the Impact on Dyslipidemia of the Addition of Tenofovir to Stable Background Antiretroviral Therapy in HIV-Infected Subjects
 A
 Aberg
 ACTG A5211: Phase II, Randomized, Double-Blind Study of the Safety and Efficacy of SCH 417690 (an Orally Administered HIV-1 Entry Inhibitor) in HIV-Infected, Treatment-Experienced Subjects
 A
 Aberg
 ACTG A5220: Improving Immune Response to Hepatitis B Vaccine in HIV-Positive Subjects Using Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF) as a Vaccine Adjuvant: A Phase II Open-Label Pilot Study\
 A
 Aberg
 ACTG A5223: Sex Differences in Lopinavir/Ritonavir Pharmacokinetics among HIV-1-Infected Men and Women
 A
 Abramson
 Leukocyte Gene Expression in Osteoarthritis
 A
 Achkar
 Immunodiagnostic Tests for the Rapid Diagnosis of TB
 A
 Axelrod
 Phase 1 Pharmacokinetic Study of Kinetin in Carriers of the Familial Dysautonomia Mis-Splicing Mutation\
 A
 Ayappa
 Relating Sleep Disordered Breathing to Daytime Function
 
 Ayappa
 Validation of Apnea Risk Evaluation Sleep Scoring
 A
 Banikazemi
 "A Phase 2, Open-Label, Multicenter Study Evaluating the Efficacy, Safety and Pharmacokinetics of Genz-112638 in Gaucher Type 1 Patients"
 D
 Becker
 Determination of the Effect of Radio-Opaque Contrast Media (CM) on Renal Function by Glomerular Filtration Rate (GFR)
 A
 Becker
 Gadolinium Nephrotoxicity: A Measurement of Glomerular Filtration Rate (GFR)
 A
 Belmont
 Lipitor to Prevent Avascular Necrosis in Systemic Lupus Erythematosus
 A
 Bhardwaj
 NYU 03-03: A Randomized, Controlled Trial of Melanoma Treatment: Comparison of Dendritic Cells Versus QS-21 as Adjuvants to Stimulate Anti-tumor Immunity, and Baseline Immune Monitoring of Melanoma Patients
 A
 Bini
 Assessment of Adrenal Function in Patients with Chronic Hepatitis C Virus Infection and Severe Fatigue
 A
 Blank
 GOG-0199: Prospective Study of Risk-Reducing Salpingo-oophorectomy and Longitudinal
 A
 Blank
 NYU 02-30: A Phase I/II Study of OSI 774 in Combination with Carboplatin and Paclitaxel in Patients with Ovarian or
 A
 Blank
 NYU 03-17: A Phase II Study of Oxaliplatin in Combination with Paclitaxel in Patients with Locally Recurrent or Metastatic Cervical Cancer
 A
 Borkowsky
 "PACTG P1038: A Phase I/II Safety, Tolerability, and Pharmacokinetic Study of High Dose Lopinavir/Ritonavir With or Without Saquinavir in HIV-Infected Pediatric Subjects Previously Treated with Protease Inhibitors"
 A
 Borkowsky
 "PENPACT 1 (PENTA 9/PACTG 390): A
 A
 Borkowsky
 A 48-Week, Phase II, Non-Comparative, Open-Label, Multi-Cohort, Multicenter Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Antiviral Activity of GW433908/Ritonavir BID when Administered to HIV-1 Infected, PI-Naive and Experienced Pediatric Subjects, 2 to 18 Years Old and of GW433908 BID Administered to PI-Naive, Pediatric Subjects 2 to <6 Years Old
 D
 Borkowsky
 ACTG 219 Pediatric Late Outcomes
 A
 Borkowsky
 P1061s: Evaluation of Immunologic Memory Following Pneumococcal, Hepatitis B, and Measles Vaccination in HIV-Infected Children Treated with Highly Active Antiretroviral Therapy (HAART)
 A
 Borkowsky
 PACTG 1020-A: Phase I/II Open-Label, Pharmacokinetic and Safety Study of a Novel Protease Inhibitor (BMS-232632) in Combination Regimens in Antiretroviral Therapy (ART)-Naive and -Experienced HIV-Infected Infants, Children and Adolescents
 A
 Borkowsky
 PACTG 1025: Perinatal Core Protocol
 A
 Borkowsky
 PACTG P1006: The Effects of Highly Active Antiretroviral Therapy (HAART) on the Recovery of Immune Function in HIV-Infected Children
 A
 Bosland
 Prostate Cancer Chemoprevention Clinical Trials
 A
 Buyon
 ACR Re-Classification of SLE Criteria (A ROSE)
 A
 Buyon
 Predictors of Pregnancy Outcomes in Systemic Lupus Erythematosus (SLE) and Antiphospholipid Syndrome (APS)
 A
 Chinitz
 Adenovirus as a Possible Etiology of Atrial Fibrillation
 A
 Clancy
 "Circulating Endothelial Cells, a Biomarker to Predict Subclinical Atherosclerosis in Patients with SLE"
 A
 Clelland
 Alzheimer's Diagnosis: Leukocyte Multigene Syndrome
 A
 Clelland
 Schizophrenia Diagnosis: Leukocyte Multigene Signatures
 A
 Coffey
 "A Double Blind, Placebo Controlled Trial of Aripiprazole in Children and Adolescents with Tourette's Disorder and Explosive Outbursts"
 A
 Coffey
 Open Label Trial of Aripiprazole in Children and Adolescents with Tourette's Disorder
 A
 Coffey
 Treatment of Adolescent Suicide
 A
 Condos
 Aerosol Deposition and Cellular Response in Patients Receiving Aerosol Interferon-gamma for Idiopathic Pulmonary Fibrosis (IPF)
 A
 Condos
 Prospective Evaluation Of Patients With Idiopathic Pulmonary Fibrosis Through An IPF Registry
 A
 Condos
 Tuberculosis Research Blood Bank
 A
 Connolly
 Quantifying Heart Failure Severity in Pediatric Patients
 A
 Convit
 "Type 2 Diabetes in Adolescence, Cognition, and the Brain"
 A
 Convit
 Brain in Diabetes: Response to Increased Metabolic Demand
 A
 Dasanayake
 Periodontal Disease and Prematurity Protocol
 A
 Feit
 Bypass Angioplasty Revascularization Investigation 2 Diabetes (BARI 2D)
 A
 Formenti
 "Response, Resistance and Metastasis of Locally-Advanced Breast Cancer (LABC) in a Multi-Ethnic Cohort"
 A
 Formenti
 NYU 00-05: Phase I Study of Bi-Weekly Taxol and Definitive Radiation in Androgen Ablated Locally Advanced Prostate Cancer
 A
 Formenti
 NYU 01-16: Locally Advanced Breast Cancer: Individualized Treatment Based on Tumor Molecular Characteristics
 A
 Francois
 The Role of Bacterial Colonization in the Development of Upper Gastrointestinal Pathology
 A
 Francois
 The Role of Inflammatory Polymorphisms in Colorectal Neoplasia
 A
 Friedberg
 Longitudinal Study of Ocular Complications of AIDS
 A
 Gabbay
 "A Double-Blind, Placebo-Controlled Study of Omega-3 Fatty Acids in Children and Adolescents with Tourette's Disorder"
 A
 Gabbay
 Immune System Activation in Adolescent Suicide
 A
 Gabbay
 Omega-3 Fatty Acids in Adolescents with Depression
 A
 Goldenberg
 NYU 03-41: Bevacizumab (RhuMab-VEGF) in Hepatocellular Cancer for Patients wtih Unresectable Tumor (without invasion of the main portal vein or metastatic disease): A Phase II Study
 A
 Grant
 Effect of Temporal Lobectomy on Sensory Deficits in Temporal Lobe Epilepsy (TLE)
 A
 Grossman
 Quantitative MR Imaging and Proton Spectroscopy in Multiple Sclerosis
 A
 Hochster
 "NYU 02-12: A Phase I and Pharmacokinetic Study of Oxaliplatin (Eloxatin) in
 A
 Hochster
 ECOG N0147: A Randomized Phase III Trial of Oxaliplatin (OXAL) Plus 5-Fluorouracil (5-FU)/Leucovorin (CF) with or without Cetuximab (C225) after Curative Resection for Patients with Stage III Colon Cancer
 A
 Hochster
 NYU 04-01: Phase I/II Dose-Escalating Study of Bi-Weekly ALIMTA and Fixed Dose
 A
 Johnson
 Pulmonary Gas Flow Measurement Using [3]He MRI
 A
 Kleinberg
 "A Phase III, Double-Blind, Randomized, Placebo-Controlled, Parallel-Group, Multicenter Study to Assess Efficacy and Safety of LB03002 Administered Weekly in Adults with Growth Hormone Deficiency [BRANY]"
 D
 Kleinberg
 "Extension to a Multicenter, Randomized, Crossover, Open-Label, Dose-Finding Study to Compare the Safety, Efficacy and PK/PD Relationship of Multiple Doses of SOM230 (200 mcg, 44 mcg and 600 mcg bid) and Doses of Open-Label Sandostatin (100 mcg tid) in Acromegalic Patients"
 D
 Krieger
 "Cellular Oxidative Stress, Serum NE and Periodic Breathing in CHF"
 A
 Krieger
 Mechanisms of Endothelial Dysfunction in Sleep Apnea
 A
 Llinas
 Functional Brain Imaging in Normal Aging
 A
 Llinas
 Magnetoencephalographic Studies of Neurologic and Psychiatric Patients
 A
 McHugh
 Development of a Mind-Body Center at NYU
 A
 Muggia
 NYU 00-60: Cancer Screening and Prevention Project for High Risk Women
 A
 Muggia
 NYU 04-26: Intraperitoneal (IP) Therapy with Cisplatin or Carboplatin and Floxuridine (FUdR) as Consolidation for Ovarian and Gastrointestinal Malignancies
 A
 Muggia
 NYU 99-55: A Phase I Study of Oral Fluoropyrimidine Capecitabine (Xeloda Roche) Combined with Intravenous Cisplatin in Patients with Advanced Cancer of the Digestive System
 A
 Norman
 Use of an Apnea Risk Evaluation System (ARES) for Diagnoses of Obstructive Sleep Apnea/Hypopnea Syndrome (OSAHS)
 A
 Novik
 ECOG PACCT-1: Trial Assigning Individualized Options for Treatment (The TAILORx Trial)\
 A
 Novik
 NSAPB-38: A Phase III, Adjuvant Trial Comparing Three Chemotherapy Regimens in Women
 A
 Oliver
 Altered Dendritic Cell Function in
 A
 Oliver
 T Cell Immunity in Collagen Biosynthesis of Scleroderma
 A
 Pena-Sing
 FREEDOM Trial: Future Revascularization Evaluation in Patients with Diabetes Mellitus: Optimal Management of Multivessel Disease
 A
 Pillon
 Trial to Reduce Cardiovascular Events with Aranesp Therapy (TREAT)
 D
 Pollack
 "Assessment of the Safety, Efficacy, Tolerability, and Pharmacokinetics of PEG-Intron Plus REBETOL in Pediatric Patients with Chronic Hepatitis C"
 D
 Pollack
 A Phase 2, Randomized, Double-Blind Study Exploring the Efficacy, Safety and Tolerability of Tenofovir Disoproxil Fumarate (DF) Monotherapy Versus Emtricitabine plus Tenofovir DF Fixed-Dose Combination Therapy in Subjects Currently Being Treated with Adefovir Dipivoxil for Chronic Hepatitis B and Having Persistent Viral Replication\
 D
 Pollack
 A Phase 3 Double Blind, Randomized, Placebo-Controlled Study of the Safety and Efficacy of Adefovir Dipivoxil in Children and Adolescents (Age 2 to <18) with Chronic Hepatitis B [BRANY]
 D
 Pomara
 A Multicenter, Randomized, 24-52 Week, double-Blind, Placebo-Controlled Study to Evaluate the Efficacy, Safety, and Tolerability of Saredutant 100 mg Once Daily in the Prevention of Relapse of Depressive Symptoms in Outpatients with Major Depressive Disorder who Achieved an Initial Response to 12 Weeks of Open-Label Treatment with Saredutant 100 mg Once Daily\
 D
 Pomara
 Long-Term Lorazepam Use and Acute Toxicity in the Elderly
 A
 Rapoport
 Impact of CPAP on Functional Outcomes in Milder OSA
 A
 Reibman
 Ambient Particulate Matter and Human Bronchial Epithelial Cells
 A
 Reibman
 Blood-Derived Dendritic Cells and Epithelial Cells
 A
 Reibman
 Bronchoalveolar Lavage and Brushings In Normal Volunteers
 A
 Reibman
 Disease Modifying Genes in Severe Asthma
 A
 Reibman
 NYU World Trade Center Responder
 A
 Reibman
 Study of Acid Reflux Asthma (SARA)
 A
 Reisberg
 Aging and Dementia Longitudinal Course of Subgroups
 A
 Ren
 The Impact of Weight Loss after Bariatric Surgery on Esophageal Function and Sleep
 A
 Reynolds
 Trial to Assess Chelation Therapy (TACT)
 A
 Rom
 Host Response to TB and AIDS
 A
 Rom
 NYU Biomarker Clinical and Epidemiologic Center
 A
 Rosenthal
 Treatment of Early Aggressive Rheumatoid Arthritis (TEAR)
 A
 Rusinek
 Alzheimer's Disease Neuroimaging Initiative
 A
 Ryan
 "NYU 04-72: Neoadjuvant Therapy of Gastric Cancer with Irinotecan, Cisplatin, and Cetuximab Followed by Surgical Resection and Adjuvant Chemoradiation"
 A
 Ryan
 NYU 03-64: A Phase I/II Study of Chemoradiation with Oxaliplatin and 5-FU for Locally
 A
 Smith
 NYU 05-151: Study of the Effects of the Aromatase Inhibitor Letrozole in Postmenopausal Women at High Risk to Develop Breast Cancer
 A
 Valentine
 The Development and Effect of HIV Specific CD4 Responses to Early Intervention in Primary HIV Infection Using Antiretroviral Therapy Alone or Antiretroviral Therapy with Vaccination
 A
 Volm
 NYU 97-39: Temodal in Patients with Advanced Malignancies
 A
 Wan
 "A Multicenter, Randomized, Double-Masked, Comparator Study of the Safety and
 A
 Wan
 A Multicenter, Open-Label Study on the Efficacy, Cycle Control and Safety of a Contraceptive Vaginal Ring Delivering a Daily Dose of 150 Micrograms of Nestorone and 15 Micrograms of Ethinyl Estradiol\
 A
 Yazici
 Hospital for Joint Diseases Arthritis Registry Monitoring Database (HJD-ARMD)
 A
 de Leon
 Biomarkers in Early Alzheimer's Disease
 A
 de Leon
 Clinical Correlates of Longitudinal PET
 A
 de Leon
 Predictors of Cognitive Decline in Normal Aging
 A